John Hardy (geneticist)

From Wikipedia, the free encyclopedia

John Hardy is a human geneticist and molecular biologist whose research interests focus on neurological disease.

[edit] Career

Hardy received his B.Sc. (Hons) degree from the University of Leeds, UK (1976)^[1] and three years later his Ph.D. from Imperial College, London, UK^[2] where he studied dopamine and amino acid neuropharmacology. Dr. Hardy performed his postdoctoral training at the MRC Neuropathogenesis Unit in Newcastle upon Tyne, England and then further postdoctoral work at the Swedish Brain Bank in Umea, Sweden where he started to work on Alzheimer's disease^[3].

He became Assistant Professor of Biochemistry at St. Mary's Hospital, Imperial College, London in 1985 and initiated genetic studies of Alzheimer's disease there^[4]. He became Associate Professor in 1989 and then took the Pfeiffer Endowed Chair of Alzheimer's Research at the University of South Florida, in Tampa in 1992. In 1996 he moved to the Mayo Clinic in Jacksonville, Florida, as Consultant and Professor of Neuroscience.

He became Chair of Neuroscience in 2000 and moved to NIA as Chief of the Laboratory of Neurogenetics in 2001. He has won the MetLife, the Allied Signal and the Potamkin Prize for his work in describing the first genetic mutations, in the amyloid gene in Alzheimer's disease, in 1991. He is currently the author of 317 articles^[5]